References
- Bogdan B, Villiger R. Valuation in Life Sciences. A Practical Guide 2008; Second Edition Springer Verlag 171 - 173
- DiMasi J, Grabowski H. The Cost of Biopharmaceutical R&D: Is Biotech Different?. Manage Decis Econ 2007; 28:469 - 479
- Reichert J. Success and failure: Clinical trials of protein therapeutics 2005; Conference on plant-made pharmaceuticals
- Reichert J, Rosensweig C, Faden L, Dewitz M. Monoclonal antibody successes in the clinic. Nat Biotechnol 2005; 23:1073 - 1078
- Reichert J. Biopharmaceutical Approvals in the US Increase. RAJ Pharma 2004;
- Schneider, Kalinke. Toward biosimilar monoclonal antibodies. Nat Biotechnol 2008; 26:985 - 990
- Longman R. Why Investor's Don't Like Biotech Alliances?. IN VIVO Blog 2008; March